$CWK

Sayed Laurida sold $222K of CWK

Sayed Laurida (See Remarks) sold 16,000 shares of Cushman & Wakefield Ltd. (CWK) at $13.88 ($0.22M total) on 2026-08-13.

Original reporting
SEC EDGAR · Sayed Laurida
Published Aug 17, 2026, 8:23 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 17, 2026, 8:44 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$CWK
Neutral
medium confidence
Mentioned
$CWK
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CWKNeutralLow
01

Why it matters

Discloses an open-market sale by an officer, with holdings after the sale reported as 5,461 shares and explicitly notes no 10b5-1 plan.

02

Market read

Traders may briefly reassess sentiment around CWK due to insider selling, but there is no accompanying operational or financial catalyst in the text.

03

What to watch

The article does not state motivations, whether shares were acquired via compensation, or whether other insiders/large holders acted similarly.

Relevance 4/10Novelty 5/10Timing: new SEC Form 4 filed 2026-08-17, covering sale dated 2026-08-13

Background

The article is an SEC Form 4 insider transaction disclosure for Cushman & Wakefield Ltd.

Company-level read

Ticker impact

$CWKNeutralMedium confidence
Context

Cushman & Wakefield insider Sayed Laurida sold 16,000 shares at $13.88 on 2026-08-13, per a new SEC Form 4 filing.

Expected impact

Likely limited, short-lived sentiment impact; any price reaction would be small unless accompanied by other company-specific news.

Evidence & confidence

Form 4 insider sales are common and often non-informational; however, the absence of a pre-arranged 10b5-1 plan can increase interpretive sensitivity for traders.

Market effects

No sector-wide signal; this is a single-insider transaction at a commercial real estate services firm.

None indicated.

None indicated.

Counterpoint

Insider sales frequently reflect diversification, taxes, or routine liquidity needs and may not indicate negative fundamentals.

Key entities

  • Cushman & Wakefield Ltd.

    Subject of the Form 4 insider sale disclosure.

  • Sayed Laurida

    Officer who sold 16,000 shares in an open-market transaction.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CWKMedAI 8/10

Cushman & Wakefield (CWK) Q2 2026 Earnings Call Transcript

Cushman & Wakefield (CWK) reported Q2 2026 revenue of $2.8 billion, up 11% in local currency, and adjusted EPS of $0.35, up 17% YoY. Leasing revenue rose 27% in local currency to $628.5 million. Net leverage fell to 3.0x after $150 million debt paydown. 2026 guidance: EPS growth 18% to 23% and revenue growth 6% to 8%.

$CWKMed

Cushman & Wakefield plc Q2 2026 Earnings Call Summary

Cushman & Wakefield plc reported record Q2 2026 total revenue and the lowest gross debt balance in its history, citing organic growth and leasing gains. It raised 2026 annual adjusted EPS growth to 18% to 23% and expects revenue growth at the mid-to-high end of 6% to 8%. Net leverage fell to 3x. Management plans to redeem $150m 2028 notes by mid-2027.

$CWKMedAI 8/10

Cushman & Wakefield Sets Second-Quarter Revenue Record

Cushman & Wakefield (C&W) reported Q2 2026 revenue up 11% to $2.8B and adjusted diluted EPS up 17% to 35 cents, beating revenue estimates by 4.6% but missing EPS expectations. The company raised full-year adjusted EPS growth guidance to 18% to 23% and cited record leasing and services revenue, with leasing revenue up 27% to $628.5M.

$CWKHigh

Cushman & Wakefield Ltd. (CWK): Results of Operations and Financial Condition

Cushman & Wakefield Ltd. (CWK) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 For Immediate Release Cushman & Wakefield Reports Financial Results for the Second Quarter 2026 Strong Leasing revenue growth of 27% (27% in local currency) Continued momentum in Services revenue growth, up 8% (7% in local currency) Achieved lowest borrowing spread o

$AZNMedAI 8/10

AstraZeneca and Vodafone: Markets live

AstraZeneca (AZN) reassured investors after the failed Wainua phase 3 trial, reaffirming mid-to-high single digit full-year revenue growth. It reported $4bn R&D spend and total sales up 6% at constant currency, with Imfinzi sales above $2bn. Vodafone (VOD) shares rose on guidance for FY27 adjusted EBITDA €13bn to €13.3bn. Other updates covered Cranswick (CWK), DCC Energy (DCC), Serica Energy (SQZ), Pharos (PHAR), and Pinewood Technologies (PINE) takeover bids.